Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
deals
life sciences
national blog main
san francisco
4
×
san francisco blog main
san francisco top stories
startups
medical device
new york blog main
raleigh-durham blog main
san diego blog main
10x genomics
acetylon pharmaceuticals
ambys medicines
astellas pharma
becton dickinson
boston blog main
boston top stories
cancer
cancer diagnostics
cell therapy
constellation pharmaceuticals
diagnostic device
fda
food and drug administration
gene therapy
genentech
genetic testing
holger willenbring
idiopathic pulmonary fibrosis (ipf)
invitae
ipo
jeffrey tong
juan carlos izpisua belmonte
keith dionne
liver disease
lung cancer
lymphoma
markus grompe
What
deal
4
×
expand
make
tests
ability
acquire
adding
aiming
aims
ambys
array
babies
big
bio
biotech
building
business
company
control
cost
deadly
debuted
decisions
developer
diagnostic
diagnostics
disease
diseases
drug
established
firm
fold
formed
future
genetic
help
invitae
launch
liver
low
Language
unset
Current search:
xconomy.com
×
deal
×
" san francisco "
×
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
Invitae Offers $55M for Singular Bio to Expand Prenatal Test Business
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed